Sutro Biopharma, Inc. (STRO)
8.60
-0.12
(-1.38%)
USD |
NASDAQ |
Nov 20, 16:00
8.60
0.00 (0.00%)
After-Hours: 20:00
Sutro Biopharma Profit Margin (Quarterly) : -346.1% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -346.1% |
| June 30, 2026 | -391.6% |
| March 31, 2026 | -265.0% |
| December 31, 2025 | -401.5% |
| September 30, 2025 | -586.6% |
| June 30, 2025 | -18.04% |
| March 31, 2025 | -436.6% |
| December 31, 2024 | -489.2% |
| September 30, 2024 | -572.6% |
| June 30, 2024 | -186.8% |
| March 31, 2024 | -447.5% |
| December 31, 2023 | 27.32% |
| September 30, 2023 | -291.2% |
| June 30, 2023 | -370.0% |
| March 31, 2023 | -394.9% |
| December 31, 2022 | -400.8% |
| September 30, 2022 | -77.50% |
| June 30, 2022 | -92.58% |
| Date | Value |
|---|---|
| March 31, 2022 | -663.2% |
| December 31, 2021 | -357.8% |
| September 30, 2021 | -362.8% |
| June 30, 2021 | -21.93% |
| March 31, 2021 | -207.1% |
| December 31, 2020 | -719.3% |
| September 30, 2020 | 96.16% |
| June 30, 2020 | |
| March 31, 2020 | -274.0% |
| December 31, 2019 | -130.8% |
| September 30, 2019 | -105.2% |
| June 30, 2019 | -131.0% |
| March 31, 2019 | -165.1% |
| December 31, 2018 | -7.82% |
| September 30, 2018 | -130.6% |
| December 31, 2017 | -379.8% |
| September 30, 2017 | -8.10% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 15.64% |
| Alnylam Pharmaceuticals, Inc. | -- |
| Anika Therapeutics, Inc. | -1.02% |
| Savara, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | -1.13K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -77.90% |
| Return on Invested Capital | -112.2% |
| Gross Profit Margin (Quarterly) | 86.33% |
| Operating Margin (Quarterly) | -241.2% |
| Return on Net Operating Assets | -564.9% |